We are live on ! Find out more
GILD icon

Gilead Sciences
GILD

948 hedge funds and large institutions have $80.8B invested in Gilead Sciences in 2013 Q2 according to their latest regulatory filings, with 948 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68% less call options, than puts

Call options by funds: $671M | Put options by funds: $2.09B

Holders
948
Holders Change
+948
Holders Change %
–
% of All Funds
30.93%
Holding in Top 10
82
Holding in Top 10 Change
+82
Holding in Top 10 Change %
% of All Funds
2.68%
New
948
Increased
–
Reduced
–
Closed
–
Calls
$671M
Puts
$2.09B
Net Calls
-$1.42B
Net Calls Change
-$1.42B

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SLI
376
Sumitomo Life Insurance
Japan
$6.83M +$6.95M +133,276 New
SAM
377
Securian Asset Management
Minnesota
$6.82M +$6.94M +133,234 New
ZIM
378
Zacks Investment Management
Illinois
$6.78M +$6.89M +132,258 New
ABC
379
Associated Banc-Corp
Wisconsin
$6.76M +$6.87M +131,811 New
PAM
380
Panagora Asset Management
Massachusetts
$6.53M +$6.65M +127,567 New
AFG
381
Albion Financial Group
Utah
$6.51M +$6.62M +126,917 New
PPCM
382
Pillar Pacific Capital Management
California
$6.46M +$6.57M +126,102 New
NLI
383
Nippon Life Insurance
Japan
$6.43M +$6.55M +125,591 New
CANY
384
Caxton Associates (New York)
New York
$6.41M +$6.52M +125,000 New
SFM
385
Soros Fund Management
New York
$6.4M +$6.52M +125,000 New
MCM
386
Mitchell Capital Management
Kansas
$6.39M +$6.5M +124,630 New
KCM
387
Kingdon Capital Management
New York
$6.35M +$6.46M +124,000 New
CTA
388
Chesley Taft & Associates
Illinois
$6.34M +$6.45M +123,725 New
RC
389
Randolph Company
Ohio
$6.34M +$6.45M +123,664 New
NIM
390
Northeast Investment Management
Massachusetts
$6.32M +$6.43M +123,270 New
NRS
391
Neville Rodie & Shaw
New York
$6.31M +$6.41M +123,030 New
GT
392
Glenmede Trust
Pennsylvania
$6.3M +$6.41M +122,943 New
MLL
393
Moody Lynn & Lieberson
Massachusetts
$6.26M +$6.36M +122,035 New
PAM
394
Private Asset Management
California
$6.16M +$6.26M +120,189 New
CPS
395
Counsel Portfolio Services
Ontario, Canada
$6.14M +$6.24M +119,777 New
MC
396
Middleton & Co
Massachusetts
$6.06M +$6.16M +118,265 New
CCM
397
Covington Capital Management
California
$6.04M +$6.14M +117,735 New
ZCM
398
Ziegler Capital Management
Illinois
$6.03M +$6.13M +117,539 New
BPB
399
Badgley, Phelps & Bell
Washington
$6.02M +$6.12M +117,468 New
GF
400
Gabelli Funds
New York
$6.01M +$6.11M +117,300 New
14 15
16
17 18

GILD Hedge Fund Activity: Q2 2013 in Review

948 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2013, worth a combined $80.8B.

Buyers outnumbered sellers: 948 funds opened new GILD positions and 0 closed out — a net gain of 948 holders — while 0 added to existing stakes and 0 trimmed.

  • 948 institutional investors held Gilead Sciences (GILD) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $80.8B of Gilead Sciences stock for Q2 2013.
  • 948 funds opened new Gilead Sciences positions in Q2 2013 and 0 closed out, a net change of +948 holders.

Based on aggregated 13F filings for Q2 2013.